BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed TARA catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:ba335ad2f7a53a721d47@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:TARA P2 readout (est.): STARBORN-1
DESCRIPTION:Safety and Efficacy Study of Intracystic TARA-002 for the Treat
 ment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Y
 ears of Age\nNCT05871970 | PHASE2 | RECRUITING | sponsor: Protara Therapeu
 tics\nPrimary completion date (ESTIMATED)\; top-line results usually follo
 w later.\nDate precision: month (shown on the first day)\nTicker TARA (con
 fidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT05871970\nSchedu
 ling/reference data from public records\; dates can move. Not investment\,
  legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05871970
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
